Therapeutic index of lymphadenectomy among patients with pancreatic neuroendocrine tumors: A multi‐institutional analysis. Issue 7 (29th August 2019)
- Record Type:
- Journal Article
- Title:
- Therapeutic index of lymphadenectomy among patients with pancreatic neuroendocrine tumors: A multi‐institutional analysis. Issue 7 (29th August 2019)
- Main Title:
- Therapeutic index of lymphadenectomy among patients with pancreatic neuroendocrine tumors: A multi‐institutional analysis
- Authors:
- Wu, Lu
Sahara, Kota
Tsilimigras, Diamantis I.
Maithel, Shishir K.
Poultsides, George A.
Rocha, Flavio G.
Weber, Sharon M.
Fields, Ryan C.
Idrees, Kamran
Cho, Clifford S.
Shen, Feng
Pawlik, Timothy M. - Abstract:
- Abstract: Background: The benefit derived from lymph node dissection (LND) in patients with pancreatic neuroendocrine tumors (pNETs) based on clinicopathological characteristics remains unclear. Methods: Patients undergoing surgery for pNET between 1997 and 2016 were identified using a multi‐institutional dataset. The therapeutic index of LND relative to patient characteristics was calculated. Results: Among 647 patients, the median number of lymph nodes (LNs) evaluated was 10 (interquartile range: 4‐16) and approximately one quarter of patients had lymph node metastasis (LNM) (N = 159, 24.6%). Among patients with LNM, 5‐year recurrence‐free survival was 56.0%, reflecting a therapeutic index value of 13.8. The therapeutic index was highest among patients with a moderately/poorly‐differentiated pNET (21.5), Ki‐67 ≥ 3% (20.1), tumor size ≥2.0 cm (20.0), and tumor location at the head of the pancreas (20.0). Patients with ≥8 LNs evaluated had a higher therapeutic index than patients who had 1 to 7 LNs evaluated (≥8: 17.9 vs 1‐7: 7.5; difference of index: 11.4). Conclusion: LND was mostly beneficial among patients with pNETs >2 cm, Ki‐67 ≥ 3%, and lesions located at the pancreatic head as identification of LNM was most common among individuals with these tumor characteristics. Evaluation of ≥8 LNs was associated with a higher likelihood of identifying LNM as well as a higher therapeutic index, and therefore this number of LNs should be considered the goal.
- Is Part Of:
- Journal of surgical oncology. Volume 120:Issue 7(2019)
- Journal:
- Journal of surgical oncology
- Issue:
- Volume 120:Issue 7(2019)
- Issue Display:
- Volume 120, Issue 7 (2019)
- Year:
- 2019
- Volume:
- 120
- Issue:
- 7
- Issue Sort Value:
- 2019-0120-0007-0000
- Page Start:
- 1080
- Page End:
- 1086
- Publication Date:
- 2019-08-29
- Subjects:
- lymphadenectomy -- pancreatic neuroendocrine tumor -- therapeutic index
Cancer -- Surgery -- Periodicals
Neoplasms -- Periodicals
616 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1096-9098 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/jso.25689 ↗
- Languages:
- English
- ISSNs:
- 0022-4790
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5067.380000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24487.xml